Teladoc Health layoffs, on the record
Every job cut, severance charge and restructuring Teladoc Health reported in its annual reports, 2023 to 2025, quoted from the filings. Headcount went from approximately 5,600 to approximately 5,600.
Headcount, as reported
| Annual report | Employees | As of |
|---|---|---|
| 10-K for 2023 | approximately 5,600 | December 31, 2023 |
| 10-K for 2024 | approximately 5,500 | December 31, 2024 |
| 10-K for 2025 | approximately 5,600 | December 31, 2025 |
Job cuts, severance and restructuring
Our summaryCompany recorded restructuring costs in 2023, of which a portion related to employee transition, severance payments, employee benefits and related costs.
Word for word“The Company recorded $ 16.9 million of restructuring costs during the year ended December 31, 2023, of which $ 7.9 million was related to employee transition, severance payments, employee benefits, and related costs and $ 9.0 million was related to costs associated with office space reductions, including $ 5.2 million of right-of-use assets impairment charges.” 10-K for 2023
Our summaryCompany recorded restructuring costs in 2022, including employee transition and severance costs.
Word for word“The Company recorded $ 7.4 million of restructuring costs during the year ended December 31, 2022, of which $ 1.4 million was related to employee transition, severance payments, employee benefits, and related costs and $ 6.0 million was related to costs associated with office space reductions, including $ 2.2 million of right-of-use assets impairment charges.” 10-K for 2023
Our summaryCompany announced a comprehensive operational review and expects further pre-tax restructuring-type charges in 2024, mainly for employee transition and severance.
Word for word“As a result of its comprehensive operational review of the business to drive efficiency in order to reduce costs and improve profit growth, the Company expects to incur pre-tax charges in the range of $ 12 million to $ 16 million in the year ending December 31, 2024, of which approximately $ 11 million is expected to occur in the quarter ending March 31, 2024.” 10-K for 2023
Our summaryCompany recorded restructuring costs for 2024, mainly employee transition and severance plus office space reductions.
Word for word“The Company recorded $ 20.4 million of restructuring costs during the year ended December 31, 2024, of which $ 11.2 million was related to employee transition, severance payments, employee benefits, and related costs and $ 6.3 million was related to costs associated with office space reductions, including $ 3.9 million of right-of-use asset impairment charges, and $ 2.9 million was for other restructuring related costs.” 10-K for 2024
Our summaryCompany recorded restructuring costs for 2023, including employee transition and severance costs and office space reductions.
Word for word“The Company recorded $ 16.9 million of restructuring costs during the year ended December 31, 2023, of which $ 7.9 million was related to employee transition, severance payments, employee benefits, and related costs and $ 9.0 million was related to costs associated with office space reductions, including $ 5.2 million of right-of-use asset impairment charges.” 10-K for 2024
Our summaryCompany described ongoing operational excellence initiatives that include restructuring, realignment and cost reduction initiatives.
Word for word“Recently we have implemented operational excellence initiatives which include a number of restructuring, realignment and cost reduction initiatives.” 10-K for 2024
Our summaryRecorded restructuring costs in 2025, mostly for employee transition and severance, plus office space reductions including right-of-use asset impairments.
Word for word“The Company recorded $ 18.8 million of restructuring costs during the year ended December 31, 2025, of which $ 12.7 million was related to employee transition, severance, employee benefits, and related costs and $ 6.1 million was related to costs associated with office space reductions, including $ 4.8 million of right-of-use asset impairment charges.” 10-K for 2025
Our summaryRecorded restructuring costs in 2024, mostly for employee transition and severance, plus office space reductions including right-of-use asset impairments.
Word for word“The Company recorded $ 20.4 million of restructuring costs during the year ended December 31, 2024, of which $ 11.2 million was related to employee transition, severance, employee benefits, and related costs and $ 6.3 million was related to costs associated with office space reductions, including $ 3.9 million of right-of-use asset impairment charges.” 10-K for 2025
Our summaryAfter year-end, the company expects further restructuring costs in 2026 to improve efficiency and profitability, mainly for employee transition, severance and office space reductions.
Word for word“Subsequent to December 31, 2025 and as a result of its review of the business to drive further efficiency, better align resources, and improve profitability, the Company expects to incur pre-tax restructuring costs under its plan in the range of $ 15.0 million to $ 20.0 million for the year ending December 31, 2026, of which approximately $ 9.0 million to $ 11.0 million is expected to be incurred in the three months ending March 31, 2026.” 10-K for 2025
| Fiscal year ended | Restructuring charges |
|---|---|
| 2018-12-31 | $1.2 million |
| 2022-12-31 | $7.4 million |
| 2023-12-31 | $16.9 million |
| 2024-12-31 | $20.4 million |
| 2025-12-31 | $18.8 million |
Teladoc Health filed 1 restructuring notice (Form 8-K, Item 2.05) since 2016. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from Teladoc Health’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-26. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.